Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Robot-Assisted Kidney Surgery Reduces Deaths, But Comparative Data Missing, Says Economist

This article was originally published in The Gray Sheet

Executive Summary

Robot-assisted surgery for kidney cancers improves outcomes by allowing partial nephrectomies, reducing mortalities and lowering some health care costs said economist Julia Thornton Snider at a Feb. 5 biomedical innovation meeting, but researchers did not compare robotic surgeries with laparoscopic or open surgeries, nor did they examine costs of deaths or other bad patient outcomes linked to robotic surgeries.

You may also be interested in...



Surgical Robot Regs To Be Addressed At FDA Gathering

The agency plans to tackle major issues related to robotically-assisted surgical devices such as safety and efficacy requirements as well as proper surgical training in what it describes is a “rapidly-developing field” during a two-day summer workshop.

ECRI Highlights Tech Hazards: Alarm Issues, Infusion Pumps Top Its 2014 List

Alarm hazards, infusion pump medication errors and CT radiation exposures in pediatric patients lead ECRI Institute’s 2014 list of the top 10 health technology hazards. Risks from networked devices and robotic surgery also made the list.

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT034502

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel